1. Merck’s HIV drug Isentress is now available as a higher-dose, once-daily formula.
2. Rebinyn is intended to treat adults and children with hemophilia B, an inherited blood disorder that causes prolonged or spontaneous bleeding.
3. Atomoxetine is a generic version of Eli Lilly’s attention-deficit/hyperactivity disorder drug, Strattera.
4. Zykadia may now be used as a first-line treatment for patients with metastatic non-small cell lung cancer whose tumors carry a specific enzyme identified through an FDA-approved test.
5. Nebivolol represents the first generic version of the hypertension drug Bystolic.
More articles on supply chain:
FDA OKs higher dose of Merck’s HIV drug
DHL exec: 3 tech solutions innovating healthcare supply chain
Exact Sciences stock jumps 12% after UnitedHealth issues positive coverage for Cologuard
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
